Skip to content

A clinical trial to study the effect of trimishrak taila matra basti in management of vatarakta

Open randomised control clinical trial of trimishrak taila matra basti in vatarakta with special reference to gout - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081087
Enrollment
60
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Dr Nayan Ashok Dhadel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having sign & symptoms of Vatarakta 2.Patient indicated for Matra Basti 3.Patient with or without elevated uric acid level but diagnosed with gout with respect clinical sign & symptoms.

Exclusion criteria

Exclusion criteria: 1.Patient contraindicated for Matra Basti 2.Pregnant women 3.Patient diagnosed with any other systemic illness which are fatal & chronic in nature

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Trimishrak Taila Matra Basti in VataraktaTimepoint: 4 weeks

Secondary

MeasureTime frame
To compare efficacy of Trimishrak Taila Matra Basti & Draksharasa Siddha Taila Matra Basti in management of VataraktaTimepoint: 1 month

Countries

India

Contacts

Public ContactDrArchana Wadkar

Hon.Shri Annasaheb Dange Ayurvedic Medical College Post Graduate And Research Centre

archanaswadkar@gmail.com9423248506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026